Platelet and Autotransfusion Device in Cardiac Surgery
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Strasbourg, France
About this trial
Cardiac surgery is a bleeding-risk surgery and frequently requires blood transfusion. Intraoperative autotransfusion devices are used to aspirate, process and retransfuse patients' blood. These devices are effective in recovering red blood cells and limiting the need for transfusion of packed red blood cells. Some devices, such as I-SEP's SAME®, can also be used to recover platelets, but their effectiveness has not yet been evaluated in real-life situations. The aim of this study is therefore to investigate the evolution of platelet counts following the use of an intraoperative recovery device in adult patients undergoing standard cardiac surgery
Eligibility criteria
Qualifiers
Patients over 18 years of age
Having undergone standard cardiac surgery (excluding redux surgery, dissection, endocarditis, circulatory assist and transplants)
Treated with an autotransfusion device during the surgery
Subject having expressed their consent to the study
Disqualifiers
Anemia less than 7 g/dL
Pregnant women
Redux surgery, dissection, endocarditis, circulatory assistance, and transplants
Contraindication to the use of an autotransfusion device
Trial design
Treatments tested in this trial
- Autotransfusion device
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov